Clinical Trials Browser

Phase 1 × Advanced Non-Small Cell Lung Cancer × Cetuximab × Clear all

NCT05504278 2025-01-27

Efficacy and Safety of IBI351 in Combination With Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer Subjects With KRAS G12C Mutation

Phase 1 Recruiting

Advanced Non-Small Cell Lung Cancer